Hypersensitivity to any dihydropyridine or any ingredient of the preparation. Lercadip is also contraindicated during pregnancy and lactation; in woman of childbearing potential unless effective contraception is used. In patients with left ventricular outflow tract obstruction, untreated congestive cardiac failure, unstable angina pectoris, severe renal or hepatic dysfunctions or within 1 month of a myocardial infarction.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
